Puma Biotechnology, Inc. (PBYI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1159522,
    "name": "Puma Biotechnology, Inc.",
    "stock_name": "Puma Biotechnology, Inc.",
    "full_name": "Puma Biotechnology, Inc.",
    "name_url": "stocks-analysis/puma-biotechnology-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.29",
    "chg": 0.42,
    "chgp": "8.62%",
    "dir": 1,
    "prev_price": "4.87",
    "mcapval": "229.69",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US74587V1070",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "842.69 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/puma-biotechnology-inc-1159522-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Puma Biotechnology, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-puma-biotechnology-inc-technically-bullish-or-bearish-3547319",
        "imagepath": "",
        "date": "2025-09-20 19:52:41",
        "description": "As of 8 August 2025, the technical trend for Puma Biotechnology, Inc. has changed from mildly bullish to bullish. The weekly MACD and Bollinger Bands are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the KST is bullish on a weekly basis but only mildly bullish monthly. The stock has performed well year-to-date with a return of 48.20%, significantly outperforming the S&P 500's 12.22% return. Overall, the current technical stance is bullish, with strength indicated by the positive momentum in MACD and Bollinger Bands, despite some mixed signals from other indicators...."
      },
      {
        "title": "Is Puma Biotechnology, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-puma-biotechnology-inc-overvalued-or-undervalued-3543720",
        "imagepath": "",
        "date": "2025-09-20 18:26:51",
        "description": "As of 7 July 2025, the valuation grade for Puma Biotechnology, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 5, a Price to Book Value of 1.90, and an EV to EBITDA ratio of 3.15, all of which suggest that the stock is trading at a discount relative to its earnings and assets.\n\nIn comparison to its peers, Puma Biotechnology's P/E ratio of 4.74 is significantly lower than Zevra Therapeutics, Inc. at 7.44, indicating a more favorable valuation. Additionally, the PEG ratio of 0.04 highlights its growth potential relative to its price, further reinforcing the undervaluation thesis. Notably, while Puma's stock has underperformed the S&P 500 in the short term, returning -9.69% over the past month compared to the index's 2.33%, it has delivered impressive returns year-to-date at 48.20%, o..."
      }
    ],
    "total": 7,
    "sid": "1159522",
    "stock_news_url": "https://www.marketsmojo.com/news/puma-biotechnology-inc-1159522"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Puma Biotechnology, Inc. technically bullish or bearish?

2025-09-20 19:52:41

As of 8 August 2025, the technical trend for Puma Biotechnology, Inc. has changed from mildly bullish to bullish. The weekly MACD and Bollinger Bands are bullish, while the daily moving averages also indicate a bullish stance. However, the weekly Dow Theory shows a mildly bearish signal, and the KST is bullish on a weekly basis but only mildly bullish monthly. The stock has performed well year-to-date with a return of 48.20%, significantly outperforming the S&P 500's 12.22% return. Overall, the current technical stance is bullish, with strength indicated by the positive momentum in MACD and Bollinger Bands, despite some mixed signals from other indicators....

Is Puma Biotechnology, Inc. overvalued or undervalued?

2025-09-20 18:26:51

As of 7 July 2025, the valuation grade for Puma Biotechnology, Inc. has moved from attractive to very attractive, indicating a strong improvement in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 5, a Price to Book Value of 1.90, and an EV to EBITDA ratio of 3.15, all of which suggest that the stock is trading at a discount relative to its earnings and assets. In comparison to its peers, Puma Biotechnology's P/E ratio of 4.74 is significantly lower than Zevra Therapeutics, Inc. at 7.44, indicating a more favorable valuation. Additionally, the PEG ratio of 0.04 highlights its growth potential relative to its price, further reinforcing the undervaluation thesis. Notably, while Puma's stock has underperformed the S&P 500 in the short term, returning -9.69% over the past month compared to the index's 2.33%, it has delivered impressive returns year-to-date at 48.20%, o...

View All News